Yahoo Finance Results
- Zacks via Yahoo FinanceNov 08 0:20 AM
Immunomedics (IMMU) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.28. This quarterly report represents an earnings surprise of ...
- Associated Press via Yahoo FinanceNov 07 23:16 PM
Immunomedics Inc. IMMU) on Wednesday reported a loss of $64.2 million in its fiscal first quarter. On a per-share basis, the Morris Plains, New Jersey-based company said it had a loss of 34 cents.
- Benzinga via Yahoo FinanceNov 04 18:35 PM
Pharmaceuticals PLC (NASDAQ: AVDL) (before the market open) Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) (before the market open) Alder Biopharmaceuticals Inc (NASDAQ: ALDR) (after the market ...
- Thomson Reuters StreetEvents via Yahoo FinanceNov 08 4:20 AM
Q1 2019 Immunomedics Inc Earnings Call MORRIS PLAINS Nov 8, 2018 (Thomson StreetEvents) -- Edited Transcript of Immunomedics Inc earnings conference call or presentation ...
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVieBenzinga via Yahoo FinanceNov 07 12:50 PM
PDL BioPharma Inc (NASDAQ: PDLI) reported a 8 percent increase in Q3 revenues to $68 million, while its net loss widened from 14 cents per share to 18 cents per share. The stock rallied ...
Immunomedics Inc. Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products.
Immunomedics, Inc. (IMMU) News – Find the latest company news headlines for Immunomedics, Inc. and all the companies you research at NASDAQ.com
Immunomedics Inc. financial and business news, updates, and information from The New York Times and other leading providers.
Immunomedics strives to improve health care and extend life by focusing on the development and commercialization of humanized monoclonal antibody-based treatments for cancer, autoimmune and other serious diseases.
Find out what works well at Immunomedics, Inc. from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read about the team’s work-life balance.
Immunomedics, Inc., (IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced that the Company will ...
View detailed financial information, real-time news, videos, quotes and analysis on Immunomedics Inc. (NASDAQ:IMMU). Explore commentary on Immunomedics Inc. and hear what the experts at TheStreet ...
Welcome to largest financial internet forum where people can hold conversations related to stock trading and investing in equities. You can share your opinion and views on various topics from ...